Filters close
Newswise: Pushing T cells down “memory lane” may improve cancer therapy
22-Jun-2022 11:00 AM EDT
Pushing T cells down “memory lane” may improve cancer therapy
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital identified proteins that help decide T cell fate and used the finding to improve CAR-T cell therapy in a solid tumor model.

Newswise: Research reveals high-risk subtype of relapsed pediatric AML
16-Feb-2022 10:00 AM EST
Research reveals high-risk subtype of relapsed pediatric AML
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have found a previously overlooked mutation in a subtype of pediatric leukemia that has implications for identifying high-risk patients.

Newswise: Research Lays a Foundation for Prevention of the Most Common Childhood Cancer
Released: 7-Feb-2022 12:05 PM EST
Research Lays a Foundation for Prevention of the Most Common Childhood Cancer
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic leukemia in mice with a genetic mutation that increases the risk of childhood cancer.

Newswise: St. Jude Children’s Research Hospital celebrates 60 years of saving children’s lives
Released: 4-Feb-2022 1:45 PM EST
St. Jude Children’s Research Hospital celebrates 60 years of saving children’s lives
St. Jude Children's Research Hospital

Diamond jubilee events planned nationwide for supporters to honor St. Jude visionaries, recognize expanding global impact of scientific, medical achievements.

Newswise: Modular super-enhancer controls retinal development
10-Jan-2022 12:25 PM EST
Modular super-enhancer controls retinal development
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.

Newswise:Video Embedded world-health-organization-and-st-jude-children-s-research-hospital-to-dramatically-increase-global-access-to-childhood-cancer-medicines
VIDEO
Released: 13-Dec-2021 8:45 AM EST
World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines
St. Jude Children's Research Hospital

The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. St. Jude is making a six-year, $200 million investment to launch the platform, which will provide medicines at no cost to countries participating in the pilot phase. This is the largest financial commitment for a global effort in childhood cancer medicines to date.

   
Newswise: Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
3-Dec-2021 2:10 PM EST
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.

Newswise: St. Jude researchers are again among the world’s most highly cited scientists
Released: 16-Nov-2021 9:55 AM EST
St. Jude researchers are again among the world’s most highly cited scientists
St. Jude Children's Research Hospital

The thirteen scientists were named to the 2021 list of Highly Cited Researchers by the Institute for Scientific Information at Clarivate, reflecting the international reach of St. Jude research.

9-Nov-2021 8:00 AM EST
Safety concerns raised for neuroblastoma candidate drug
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.

Newswise:Video Embedded together-by-st-jude-teaches-children-about-the-covid-19-vaccines-in-new-coloring-book
VIDEO
Released: 2-Nov-2021 10:00 AM EDT
Together by St. Jude Teaches Children about the COVID-19 Vaccines in New Coloring Book
St. Jude Children's Research Hospital

Following FDA authorization of the COVID-19 vaccine for 5- to 11-year-olds, Together by St. Jude releases a free coloring book that educates children on COVID-19 vaccines.

   
Newswise: Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma
Released: 21-Oct-2021 11:30 AM EDT
Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma
St. Jude Children's Research Hospital

Findings from St. Jude Children’s Research Hospital show that cell-free DNA in cerebrospinal fluid can be used to detect measurable residual disease and identify patients at risk of relapse.

Released: 18-Oct-2021 10:00 AM EDT
Powered by St. Jude, Together, a Web-Based Patient Education Resource on Childhood Cancer, Plans to Launch in Seven New Languages
St. Jude Children's Research Hospital

Together by St. Jude announces plans to launch in seven new languages, offering trustworthy medical information about pediatric cancer and shared stories of hope to families around the world

Released: 13-Oct-2021 6:05 PM EDT
David Rogers Honored by American College of Clinical Pharmacy
St. Jude Children's Research Hospital

The chair of Pharmaceutical Sciences at St. Jude Children's Research Hospital will receive two top science honors from the American College of Clinical Pharmacy at its annual meeting. It is highly unusual for both to be presented to the same person in the same year.

Released: 11-Oct-2021 8:00 AM EDT
St. Jude acquires a facility dog for employee support
St. Jude Children's Research Hospital

Rosalie, a 60-pound golden retriever, joins St. Jude as a facility dog in the Staff Resilience Center dedicated to supporting employees.

Newswise: Control of rhabdomyosarcoma cell identity provides clues to possible treatments
Released: 17-Sep-2021 8:25 AM EDT
Control of rhabdomyosarcoma cell identity provides clues to possible treatments
St. Jude Children's Research Hospital

Findings from St. Jude Children’s Research Hospital show how control of transcription factors by a common tumor suppressor gene may provide a therapeutic opportunity in a type of childhood cancer.

Newswise: Research provides evidence for how a key transcription factor manages access to DNA
Released: 7-Sep-2021 10:25 AM EDT
Research provides evidence for how a key transcription factor manages access to DNA
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists have revealed a previously unknown role for CTCF, a pivotal transcription regulator linked to cancer.

Newswise: The PANoptosome: a new frontier in innate immune responses
1-Sep-2021 10:00 AM EDT
The PANoptosome: a new frontier in innate immune responses
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists detail how inflammasomes act as integral components of mega-cell death complexes called PANoptosomes for host defense in live viral and bacterial infections.

Released: 30-Aug-2021 11:05 AM EDT
St. Jude and leading cancer centers urge vaccination to protect against HPV and other diseases
St. Jude Children's Research Hospital

NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus.

25-Aug-2021 2:00 PM EDT
COVID-19 in children with cancer: Severe disease and disrupted treatment
St. Jude Children's Research Hospital

Scientists from St. Jude Children’s Research Hospital and the International Society of Paediatric Oncology report results from the Global Registry of COVID-19 and Childhood Cancer.

Released: 5-Aug-2021 10:30 AM EDT
Retinoblastoma Resource: Researchers Create More Accurate Research Model
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists have created a model of the rare pediatric eye cancer that more closely mimics the biology of patient tumors.



close
0.70906